Fig. 3From: Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98Kaplan-Meier estimate of breast cancer-free interval by cross-classified AR expression and treatment in monotherapy population. AR expression is defined as ≥ 1% positive, < 1% negativeBack to article page